Comparison of using of recombinant Fsh long time with or without hMG in IVf/ICSI cycles
Phase 3
- Conditions
- Female infertility associated with anovulation.Female infertility associated with anovulation
- Registration Number
- IRCT201404065181N13
- Lead Sponsor
- vhice chancellor of
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Inclusion Criteria:All patients agreed upon ESHRE Criteria 2011 ,advanced maternal age( >40 years )? previous poor ovarian respond (POR)? abnormal ovarian reserve Test ( AFC=5-7, AMH=0.5-1.1)are enrolled.
Exclusion Criteria
Cigaret user; history of ovarian cyst or surjeri in ovary;primary sensitivity to Cinal Or Gonal-F ; Tumors depended to Sex in reproductive systhem ;Adrenal failure or oncontrlod Thyroid;andometriosis;couple chromosomal difficulties;ovulatory dysfunction ( hypogonadic or hypergonadic infertility , hyperprolactinemia,thyroid disease, neoplastic ovary and adrenal,Kushing syndrome).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mature oocyte. Timepoint: time of getting oocyte. Method of measurement: microscopic assay.;Number of fetus. Timepoint: two days after getting of oocytes. Method of measurement: microscopic assay by embryologists.
- Secondary Outcome Measures
Name Time Method Days of ovulation induction. Timepoint: Medication at the time of ovulation induction. Method of measurement: Patient records.;Abortion. Timepoint: two weeks after embryo transfer. Method of measurement: transvaginal sonography and blood test.;Pregnancy. Timepoint: two weeks after embryo transfer. Method of measurement: transvaginal sonography and blood test.